Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression-Reference-Cited by-同舟云学术

Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

Published:2017-03-09 Issue:1 Volume:9 Page:
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alz Res Therapy

Author:

Hesse Raphael,Lausser Ludwig,Gummert Pauline,Schmid Florian,Wahler Anke,Schnack Cathrin,Kroker Katja S.,Otto Markus,Tumani Hayrettin,Kestler Hans A.,Rosenbrock Holger,von Arnim Christine A. F.

Funder

Boehringer Ingelheim Ulm University BioCenter (BIU)

Ernst Schering Foundation (DE)

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Link

http://link.springer.com/content/pdf/10.1186/s13195-017-0245-y.pdf

Reference81 articles.

1. Conti M, Beavo J. Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem. 2007;76:481–511.

2. Lu YF, Kandel ER, Hawkins RD. Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus. J Neurosci. 1999;19(23):10250–61.

3. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci. 1998;21:127–48.

4. Sheng M, Sabatini BL, Südhof TC. Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol. 2012;4(5):1-2.

5. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med. 2010;362(4):329–44.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody-assisted selective isolation of Purkinje cell nuclei from mouse cerebellar tissue;Cell Reports Methods;2024-07

2. Sildenafil Reverses the Neuropathological Alzheimer’s Disease Phenotype in Cholinergic-Like Neurons Carrying the Presenilin 1 E280A Mutation;Journal of Alzheimer's Disease;2024-05-14

3. Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases;Medicinal Research Reviews;2024-01-27

4. Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 pathway, endoplasmic reticulum stress, and cellular senescence;Inflammopharmacology;2023-07-17

5. First‐in‐human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS‐penetrant soluble guanylyl cyclase stimulator;Clinical and Translational Science;2023-05-03